175 related articles for article (PubMed ID: 23987918)
1. Prevalence of schistosome antibodies with hepatosplenic signs and symptoms among patients from Kaoma, Western Province, Zambia.
Payne L; Turner-Moss E; Mutengo M; Asombang AW; Kelly P
BMC Res Notes; 2013 Aug; 6():344. PubMed ID: 23987918
[TBL] [Abstract][Full Text] [Related]
2. Morbidity associated with Schistosoma mansoni infection in north-eastern Democratic Republic of the Congo.
Nigo MM; Odermatt P; Nigo DW; Salieb-Beugelaar GB; Battegay M; Hunziker PR
PLoS Negl Trop Dis; 2021 Dec; 15(12):e0009375. PubMed ID: 34855763
[TBL] [Abstract][Full Text] [Related]
3. Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors.
Mueller A; Fuss A; Ziegler U; Kaatano GM; Mazigo HD
BMC Infect Dis; 2019 Oct; 19(1):832. PubMed ID: 31590657
[TBL] [Abstract][Full Text] [Related]
4. [Relation between Shistosoma mansoni and hepatosplenomegalies].
Rakotonirina EJ; Andrianjaka P; Rakotoarivelo RA; Ramanampamonjy RM; Randria MJ; Rakotomanga JD
Sante; 2010; 20(1):15-9. PubMed ID: 20350861
[TBL] [Abstract][Full Text] [Related]
5. Hepatosplenic morbidity due to Schistosoma mansoni in schoolchildren on Ukerewe Island, Tanzania.
El Scheich T; Hofer L; Kaatano G; Foya J; Odhiambo D; Igogote J; Lwambo N; Ekamp H; Karst K; Häussinger D; Richter J
Parasitol Res; 2012 Jun; 110(6):2515-20. PubMed ID: 22215193
[TBL] [Abstract][Full Text] [Related]
6. Hepatosplenic schistosomiasis is characterised by high blood markers of translocation, inflammation and fibrosis.
Sinkala E; Kapulu MC; Besa E; Zyambo K; Chisoso NJ; Foster GR; Kelly P
Liver Int; 2016 Jan; 36(1):145-50. PubMed ID: 26058680
[TBL] [Abstract][Full Text] [Related]
7. High Schistosoma mansoni disease burden in a rural district of western Zambia.
Mutengo MM; Mwansa JC; Mduluza T; Sianongo S; Chipeta J
Am J Trop Med Hyg; 2014 Nov; 91(5):965-72. PubMed ID: 25246696
[TBL] [Abstract][Full Text] [Related]
8. Human schistosomiasis mansoni: immune responses during acute and chronic phases of the infection.
Caldas IR; Campi-Azevedo AC; Oliveira LF; Silveira AM; Oliveira RC; Gazzinelli G
Acta Trop; 2008; 108(2-3):109-17. PubMed ID: 18577364
[TBL] [Abstract][Full Text] [Related]
9. Clinical and endoscopic aspects of hepatosplenic schistosomiasis in Uganda.
Ravera M; Reggiori A; Cocozza E; Ciantia F; Riccioni G
Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):693-7. PubMed ID: 8853260
[TBL] [Abstract][Full Text] [Related]
10. Patients with severe schistosomiasis mansoni in Ituri Province, Democratic Republic of the Congo.
Nigo MM; Odermatt P; Nigo DW; Salieb-Beugelaar GB; Battegay M; Hunziker PR
Infect Dis Poverty; 2021 Mar; 10(1):39. PubMed ID: 33762007
[TBL] [Abstract][Full Text] [Related]
11. Contribution of Schistosoma mansoni to systemic inflammation and microbial translocation among people with HIV in Zambia.
Furch BD; Mwakamui S; Sianongo S; Zyambo K; Heimburger DC; Koethe JR; Kelly P
Trans R Soc Trop Med Hyg; 2022 Feb; 116(2):179-186. PubMed ID: 34263318
[TBL] [Abstract][Full Text] [Related]
12. Detailed clinical and ultrasound examination of children and adolescents in a Schistosoma mansoni endemic area in Kenya: hepatosplenic disease in the absence of portal fibrosis.
Vennervald BJ; Kenty L; Butterworth AE; Kariuki CH; Kadzo H; Ireri E; Amaganga C; Kimani G; Mwatha J; Otedo A; Booth M; Ouma JH; Dunne DW
Trop Med Int Health; 2004 Apr; 9(4):461-70. PubMed ID: 15078264
[TBL] [Abstract][Full Text] [Related]
13. High levels of IgG4 to Schistosoma mansoni egg antigens in individuals with periportal fibrosis.
Silveira AM; Bethony J; Gazzinelli A; Kloos H; Fraga LA; Alvares MC; Prata A; Guerra HL; Loverde PT; Correa-Oliveira R; Gazzinelli G
Am J Trop Med Hyg; 2002 May; 66(5):542-9. PubMed ID: 12201588
[TBL] [Abstract][Full Text] [Related]
14. Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: clinical, ultrasonographical and biochemical parameters.
Kardorff R; Gabone RM; Mugashe C; Obiga D; Ramarokoto CE; Mahlert C; Spannbrucker N; Lang A; Günzler V; Gryseels B; Ehrich JH; Doehring E
Trop Med Int Health; 1997 Mar; 2(3):230-9. PubMed ID: 9491101
[TBL] [Abstract][Full Text] [Related]
15. Comparison of immune responses of Schistosoma mansoni-infected mice with distinct chronic forms of the disease.
Silva LM; Oliveira SA; Ribeiro-dos-Santos R; Andrade ZA; Soares MB
Acta Trop; 2004 Jul; 91(2):189-96. PubMed ID: 15234668
[TBL] [Abstract][Full Text] [Related]
16. [Decompensated post-schistosomiasis portal hypertension in Richard-Toll, Senegal: first case treated by splenorenal anastomosis in Dakar].
Imbert P; Gérardin P; Ka AS; Andreu JM; Cassagnou M; Klotz F
Bull Soc Pathol Exot; 2003 Aug; 96(3):196-9. PubMed ID: 14582295
[TBL] [Abstract][Full Text] [Related]
17. Urban schistosomiasis: morbidity, sociodemographic characteristics and water contact patterns predictive of infection.
Firmo JO; Lima Costa MF; Guerra HL; Rocha RS
Int J Epidemiol; 1996 Dec; 25(6):1292-300. PubMed ID: 9027538
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of schistosomiasis in Egypt: Gharbia Governorate.
El-Hawey AM; Amr MM; Abdel-Rahman AH; El-Ibiary SA; Agina AM; Abdel-Hafez MA; Waheeb AA; Hussein MH; Strickland GT
Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):42-8. PubMed ID: 10813499
[TBL] [Abstract][Full Text] [Related]
19. Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel.
Sukwa TY; Bulsara MK; Wurapa FK
J Trop Med Hyg; 1987 Aug; 90(4):205-11. PubMed ID: 3116277
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal.
Gryseels B; Stelma FF; Talla I; van Dam GJ; Polman K; Sow S; Diaw M; Sturrock RF; Doehring-Schwerdtfeger E; Kardorff R
Trop Geogr Med; 1994; 46(4 Spec No):209-19. PubMed ID: 7825223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
